A Bio-Psycho-Social Medical Model-Based Study on Adolescent Female HPV Vaccination Behavior and Comprehensive Intervention
NCT07562984 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2026-05-01
Summary
Based on the biopsychosocial (BPS) medical model, this study focuses on HPV vaccination behavior among adolescent females. It aims to explore the influence of multidimensional factors-including biological characteristics, psychological factors, and family and social environments-on vaccination behavior, and to evaluate the effectiveness of a comprehensive HPV vaccination intervention program designed for joint participation by adolescents and their parents.
This study employs a prospective, multicenter, randomized, open-label, parallel-group design. Participants-girls and adolescents aged 9-17 who are scheduled to receive or have not yet completed HPV vaccination, along with their primary caregivers-were recruited from our hospital and collaborating pediatric/maternal and child health institutions both domestically and internationally. Participants were randomly assigned in a 1:1 ratio to an intervention group and a control group.
In addition to routine vaccination clinic counseling, the intervention group received a comprehensive HPV vaccination intervention program based on the BPS model, including: structured health education materials (illustrated booklets/short videos); structured communication and shared decision-making support in the clinic setting; continuous information dissemination and vaccination reminders via platforms such as WeChat; and personalized follow-up and Q\&A sessions for families with high vaccine hesitancy; The control group received standard routine education and vaccination services.
The primary outcome was the proportion of adolescents who completed the first dose of the HPV vaccine within 3 months of enrollment; secondary outcomes included the proportion completing the full vaccination series within 6 months, changes in vaccine hesitancy levels and HPV-related knowledge, changes in anxiety/depression levels among adolescents and caregivers, and changes in the quality of parent-child communication regarding health and vaccination as well as family decision-making patterns.
This study is expected to identify key bio-psycho-social determinants of HPV vaccination behavior among adolescent females, validate the effectiveness of the comprehensive BPS intervention in increasing vaccination rates and improving decision-making experiences and psychosocial outcomes, and provide evidence-based guidance and scalable practical pathways for pediatric and related specialty clinics to implement adolescent vaccination health promotion and family shared decision-making services.
Conditions
- HPV
- Vaccination Hesitancy
- Biopsychosocial Model
Interventions
- BEHAVIORAL
-
the BPS-based comprehensive intervention
1 Biological 1. Briefly assess reproductive risks (history, menstruation); explain HPV-cancer link, vaccine types/schedules plainly. 2. Provide graphic handouts: HPV basics, vaccine types/procedures, adverse reaction mgmt, contraindications. 2 Psychological 1. Baseline: use short PACV \& DCS to assess caregiver hesitancy/decisional conflict, identify high-risk families. 2. 5-10 min structured shared decision-making: a) identify concerns/needs; b) risk-benefit; c) elicit values; d) weigh options (now/delay/decline). 3. High hesitancy/conflict: one phone/online follow-up in 1-2 mo - clarify misunderstandings, address concerns, provide support. 3 Social 1. WeChat/SMS: send HPV/vaccine info \& reminders (e.g., next doses). 2. Tip cards encouraging parent-child talk on HPV, sexual health, vaccination - respect privacy, shared decisions. 3. Assess family decision patterns; safely boost adolescent voice. 4. Unified training; quality monitor via on-site supervision \& sampled interviews.
Sponsors & Collaborators
-
The Children's Hospital of Zhejiang University School of Medicine
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 9 Years
- Max Age
- 17 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-04-30
- Primary Completion
- 2028-11-30
- Completion
- 2028-11-30
More Related Trials
-
Impact of a School- and Primary Care-based Multicomponent Intervention on HPV Vaccination Acceptability
NCT04945655 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Impact of a HPV Vaccination Talk with Third Grade Students
NCT06631794 ·Status: NOT_YET_RECRUITING
-
Facilitating Completion of HPV Vaccination
NCT01600560 ·Status: COMPLETED
-
Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination
NCT02537756 ·Status: COMPLETED ·Phase: NA
-
Active Health Education to Increase HPV Vaccine Coverage in Youth: A Stepped-wedge, Cluster, and Randomized Trial
NCT06513494 ·Status: RECRUITING ·Phase: NA
-
Effectiveness of Vaccine Chatbot on HPV Vaccine Awareness and Vaccination in China
NCT06227689 ·Status: RECRUITING ·Phase: NA
-
The STOP-HPV Trial 4: Bundle Intervention
NCT03609242 ·Status: UNKNOWN ·Phase: NA
-
The STOP-HPV Trial 1: Communication Intervention
NCT03599557 ·Status: COMPLETED ·Phase: NA
-
PREVENT Pilot HPV - Related Cancers Trial
NCT06738355 ·Status: COMPLETED ·Phase: NA
-
Video to Promote HPV Vaccination
NCT02196454 ·Status: COMPLETED ·Phase: NA
-
Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls
NCT03206255 ·Status: COMPLETED
-
A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine
NCT05680454 ·Status: COMPLETED ·Phase: PHASE1
-
Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination: Feasibility Trial
NCT02535845 ·Status: TERMINATED ·Phase: NA
-
The STOP-HPV Trial 3: Prompts Intervention
NCT03599583 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness and B-memory Cell Response to QHPV Vaccine 9-years Post-vaccination Among HIV-infected Boys and Girls
NCT04920526 ·Status: UNKNOWN
-
Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls
NCT06243666 ·Status: ACTIVE_NOT_RECRUITING
-
Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness
NCT05006833 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years
NCT07281677 ·Status: RECRUITING ·Phase: PHASE4
-
Intervention for Human Papillomavirus Vaccine Acceptance in Mexican Mothers
NCT06854354 ·Status: COMPLETED ·Phase: NA
-
Study on the Epidemiological Characteristics of Female HPV Vaccination in China
NCT05932563 ·Status: UNKNOWN
-
Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
NCT05371353 ·Status: RECRUITING
-
Improving HPV Vaccination Rates Among Rural and Native American Adolescents
NCT03801603 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China
NCT05662020 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting
NCT00572832 ·Status: COMPLETED ·Phase: NA
-
A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls
NCT02562508 ·Status: COMPLETED ·Phase: PHASE3